AT1 8.70% 2.1¢ atomo diagnostics limited

Media Update, page-1029

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    eh..what?! Will this bring about a resurgence in the NGBio partnership or is this a knowledge brain drain into a potential competitor?

    NG Biotech S.A.S. (NG) announced today the appointment of Fabio Baglioni as Chief Commercial Officer (CCO) to spearhead the next phase of the company’s ambitious growth strategy.
    https://ngbiotech.com/news/ng-biotech-expands-senior-management-team-to-continue-impressive-growth-trend/

    "Mr Baglioni joins the company with significant commercial experience, having most recently been CCO for Australian medical device developer Atomo Diagnostics Ltd (ASX:AT1)......"
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
-0.002(8.70%)
Mkt cap ! $13.42M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $219 10.44K

Buyers (Bids)

No. Vol. Price($)
3 533049 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 269439 3
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.